FDA clearance to Interrad’s SecurAcath Securement System
The U.S. Food and Drug Administration has given the 510(k) clearance Interrad Medical, Inc.’s SecurAcath(TM) PICC with Subcutaneous Securement System. The novel method for catheter securement uses a small anchor which is deployed in the subcutaneous tissue just under the skin to hold an indwelling catheter firmly in place. The catheters, currently in use, are secured on the surface of the skin of the patient using adhesive devices. The SecurAcath system also reduces the time for catheter maintenance, bringing down the costs related to it. The risk of infection related to catheter is also lowered by improved cleaning of exit site and minimizing the motion.
- FDA clears Cardica’s PAS-Port for commercial launch
- CorMatrix receives clearance to use CorMatrix ECM in Cardiac Tissue Repair
- InfraReDx receives FDA nod for its catheter imaging device
- FDA nod to Lumen’s LBI Embolectomy System
